F11R peptide (TFA)

F11R peptide TFA is a F11 receptor molecule. F11R peptide TFA inhibits anti-F11R antibody-induced platelet aggregation, and inhibits the adhesion of platelets to cytokine (TNFα and INF-γ) -inflammed endothelial cells. F11R peptide TFA can be used for research of atherosclerotic plaques and associated thrombotic disease[1].

Product Specifications

UNSPSC

12352209

Target

Others

Related Pathways

Others

Applications

COVID-19-immunoregulation

Field of Research

Inflammation/Immunology

Purity

97.58

Smiles

OC(C=C1)=CC=C1C[C@H](NC([C@H]([C@H](O)C)NC(CNC([C@H]([C@H](O)C)NC([C@H](CC(O)=O)NC([C@H](CCC(O)=O)NC([C@@H](CCCNC(N)=N)NC([C@H]([C@H](O)C)NC([C@H](C(C)C)NC([C@H](CO)NC([C@H](N)CCCCN)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)C(N[C@@H]([C@H](O)C)C(N[C@@H](CS)C(N)=O)=O)=O.O=C(C(F)(F)F)O.[x]

Molecular Formula

C59H98N18O23S.xC2HF3O2

Molecular Weight

1459.58 (free base)

References & Citations

[1]Babinska A, et al. Development of new antiatherosclerotic and antithrombotic drugs utilizing F11 receptor (F11R/JAM-A) peptides. Biopolymers. 2014 Jul;102 (4) :322-34.